Jump to content


Long-time Board Member
  • Content Count

  • Joined

  • Last visited

Community Reputation

0 Neutral

About drmeriftr

  • Rank
    Long-time Board Member

Contact Methods

  • Website URL

Profile Information

  • Gender
  • Location

Recent Profile Visitors

1,956 profile views
  1. Hi Meri! Thanks for your comment a long time ago, thought I would say hi back!:)

  2. Scientists Unravel Clue in Cortisol Production Atlanta (April 24, 2007) ? When a person?s under stress or injured, the adrenal gland releases cortisol to help restore the body?s functions to normal. But the hormone?s effects are many and varied, lowering the activity of the immune system, helping create memories with short-term exposure, while impairing learning if there?s too much for too long. Given the variety of its effects,understanding how cortisol is made is essential to producing medications that can alter its production. Scientists at the Georgia Institute of Technology have
  3. Congratulations to everyone who worked on Officially Designating April 8th as Cushing's Awareness Day!! This is awesome!! I found the bill here: http://thomas.loc.gov/cgi-bin/query/z?c110:S.RES.127: Designating April 8, 2007, as `National Cushing's Syndrome Awareness Day'. (Agreed to by Senate) SRES 127 ATS 110th CONGRESS 1st Session S. RES. 127 Designating April 8, 2007, as `National Cushing's Syndrome Awareness Day'. IN THE SENATE OF THE UNITED STATES March 27, 2007 Mr. INHOFE (for himself and Mr. DODD) submitted the following resolution; which was
  4. Hey! Thought I'd say "hi!" Hava great day!!:~P

  5. A study by University College London (Oct. 2006) revealed that people who drank tea after stressful events were able to de-stress more quickly than those who did not drink tea. The researchers discovered that black tea lowers the levels of cortisol, a harmful stress hormone, by a significant average of 47 percent. No distinction was referenced between decafinated or regular tea. http://www.businessportal24.com/en/Black_T...ing_143589.html
  6. Mortality in Patients Treated for Cushing?s Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma O. M. Dekkers, N. R. Biermasz, A. M. Pereira, F. Roelfsema, M. O. van Aken, J. H. C. Voormolen and J. A. Romijn Departments of Endocrinology and Metabolic Diseases (O.M.D., N.R.B., A.M.P., F.R., M.O.v.A., J.A.R.), Neurosurgery (J.H.C.V.), and Clinical Epidemiology (O.M.D.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands Address all correspondence and requests for reprints to: O. M. Dekkers, M.D., M.A., Department of Endocrinolo
  7. http://www.primenewswire.com/newsroom/news.html?d=113205 Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for Cushing's Syndrome Files New Patent Application for SP-6300 Making Use of SP-01A's Phase II Study Data Drug SP-01A (HIV), SP-6300 (Cushing's) Demonstrates a Statistically Significant Ability to Normalize High Cortisol in Humans High Cortisol Cushing's is Caused by a Long-Term Use of Corticosteroid Medications (Normally Administered to Lupus, Asthma, and Rheumatoid Arthriti
  8. Hi MaryO, I would also be interested in car ribbon magnets for Cushing's Awareness. Are they available? Thank you!! Meri
  9. Novartis Highlights Strong R&D Pipeline, Plans for Multiple New Product Launches and Novel Projects Moving Into Late-stage Trials (bits & pieces of the press release) ...Late-stage compounds moving into pivotal trials - FTY720 (multiple sclerosis), QAB149 (COPD/asthma), AGO178 (depression), ABF656 (hepatitis C), RAD001 (cancer) and SOM230 (Cushing's disease) ... ...The following compounds are moving into pivotal late-stage trials: FTY720 (fingolimod) for multiple sclerosis, QAB149 (indacaterol) for COPD and asthma, AG0178 (agomelatine) for depression and ABF656 (Albufero
  10. The Effects of SOM230 on Cell Proliferation and Adrenocorticotropin Secretion in Human Corticotroph Pituitary Adenomas Dalia L. Batista, Xun Zhang, Roger Gejman, Peter J. Ansell, Yunli Zhou, Sarah A. Johnson, Brooke Swearingen, E. Tessa Hedley-Whyte, Constantine A. Stratakis and Anne Klibanski Neuroendocrine Unit (D.L.B., X.Z., P.J.A., Y.Z., S.A.J., A.K.), Neuropathology Unit (R.G., E.T.H.-W.), and Division of Neurosurgery (B.S.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; and Section on Endocrinology and Genetics (D.L.B., C.A.S.), Developmenta
  11. Sorry, I did not realize that the article had already been posted here-I was just so surprised that my sister told me about it! I have not been able to keep up with the boards recently, otherwise, it appears I would have known about it ten days ago! Thanx for sharing the article and information! Take care. Meri
  • Create New...